Background:
• Atrial Fibrillation is one of the most common cardiac arrhythmias with a prevalence of ~2.5million people in the US, and that number is expected to double in the next 30 years.
• Approximately 1/3 of cardiovascular hospital admissions are due to atrial fibrillation.
• Patients with atrial fibrillation have increased cardiac complications during the first year post diagnosis (HF, stroke, chest pain, MI, tachycardia, palpitations) than those without the disease.
• Treatment of patients with atrial fibrillation is complex and it involves controlling heart rate, converting to and maintaining sinus rhythm, and prevention of thromboembolic events.
• One of the biggest challenges in the management of atrial fibrillation is non-adherence
• Atrial Fibrillation is one of the most common cardiac arrhythmias with a prevalence of ~2.5million people in the US, and that number is expected to double in the next 30 years.
• Approximately 1/3 of cardiovascular hospital admissions are due to atrial fibrillation.
• Patients with atrial fibrillation have increased cardiac complications during the first year post diagnosis (HF, stroke, chest pain, MI, tachycardia, palpitations) than those without the disease.
• Treatment of patients with atrial fibrillation is complex and it involves controlling heart rate, converting to and maintaining sinus rhythm, and prevention of thromboembolic events.
• One of the biggest challenges in the management of atrial fibrillation is non-adherence